Basic information Safety Supplier Related

Fatostatin A

Basic information Safety Supplier Related

Fatostatin A Basic information

Product Name:
Fatostatin A
Synonyms:
  • Fatostatin A
  • 4-[4-(4-Methylphenyl)-2-thiazolyl]-2-propylpyridine MonohydrobroMide
  • Fatostatin A HydrobroMide
  • 2-(2-propylpyridin-4-yl)-4-p-tolylthiazole hydrobromide
  • 25B11 hydrobromide
  • 4-[4-(4-methylphenyl)-2-thiazolyl]-2-propylpyridine hydrobromide
  • Fatostatin hydrobromide
  • Fatostatin
CAS:
298197-04-3
MF:
C18H19BrN2S
MW:
375.33
Product Categories:
  • Aromatics, Heterocycles, Inhibitors, Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Selenium Compounds
  • API
Mol File:
298197-04-3.mol
More
Less

Fatostatin A Chemical Properties

storage temp. 
2-8°C
solubility 
DMSO: ≥10mg/mL
form 
powder
color 
light yellow to yellow
More
Less

Safety Information

Hazard Codes 
Xn
Risk Statements 
22
WGK Germany 
1
More
Less

Fatostatin A Usage And Synthesis

Uses

Fatostatin hydrobromide has been used:

  • to study its anti-cancer activity and effects on mitotic microtubule spindle
  • to study its effects on stomatal development
  • to prevent SREBP cleavage-activating protein (SCAP)-mediated escort of sterol regulatory element-binding proteins (SREBPs)

Uses

Fatostatin A is an inhibitor of sterol regulatory element binding protein (SREBP). Fatostatin A reverses hyperglycemia in diabetic mice. Cell permeable. Fatostatin A is used for the treatment and/or prevention of one or more metabolic disorders.

General Description

Fatostatin is a non-sterol diarylthiazole derivative. It prevents insulin-induced adipogenesis and lowers the amounts of fatty acid, triglyceride and low-density lipoprotein. Fatostatin has anti tumor and antimitotic properties.

Biological Activity

fatostatin a is an inhibitor of sterol regulatory element binding protein (srebp), which can inhibit the activation of srebp-1 and srebp-2[1].fatostatin a (0.1-1 μm; 3 days) inhibits the androgen-independent proliferation of prostate cancer cell in a manner independent of the known igf1 signaling pathway. fatostatin a inhibits insulin-induced fat formation in 3t3-l1 cells[2].fatostatin a (30 mg/kg; 150 ml; i.p.; daily for 28 days) prevents obese ob/ob mice from increasing their weight, blood sugar, and liver fat accumulation, even if they do not control the food intake of mice[1].[1]. kamisuki s, et al. a small molecule that blocks fat synthesis by inhibiting the activation of srebp. chem biol. 2009, 16(8): 882-92.[2]. choi y, et al. identification of bioactive molecules by adipogenesis profiling of organic compounds. j biol chem. 2003, 278(9): 7320-4.

Biochem/physiol Actions

Fatostatin hydrobromide is an SREBP inhibitor. Fatostatin hydrobromide inhibits fat production and lowers glucose levels in mice by inhibiting SREBP (Sterol Regulatory Element Binding Proteins).

storage

Store at +4°C

Fatostatin ASupplier

J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
Adamas Reagent, Ltd.
Tel
400-6009262 16621234537
Email
zhangsn@titansci.com
Chemsky (shanghai) International Co.,Ltd
Tel
021-50135380
Email
shchemsky@sina.com
Shanghai TaoSu Biochemical Technology Co., Ltd.
Tel
021-33632979
Email
info@tsbiochem.com
ShangHai Caerulum Pharma Discovery Co., Ltd.
Tel
18149758185
Email
sales-cpd@caerulumpharma.com